𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Postmenopausal hormone therapy and cancer risk

✍ Scribed by P. Kenemans; R.A. Verstraeten; R.H.M. Verheijen


Book ID
116537560
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
96 KB
Volume
1279
Category
Article
ISSN
0531-5131

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Postmenopausal hormone therapy and breas
✍ Sulggi Lee; Laurence Kolonel; Lynne Wilkens; Peggy Wan; Brian Henderson; Malcolm πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 95 KB πŸ‘ 2 views

## Abstract Epidemiological studies indicate that menopausal estrogen‐progestin therapy (EPT) use is associated with an increase in breast cancer risk. Further data are needed on whether this association varies by specific prognostic factors and ethnicity. We conducted a cohort study among 55,371 A

Obesity, hormone therapy, estrogen metab
✍ Francesmary Modugno; Kevin E. Kip; Barbara Cochrane; Lewis Kuller; Thomas L. Klu πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 302 KB πŸ‘ 2 views

## Abstract Hormone therapy (HT) and body mass index (BMI) have been associated with postmenopausal breast cancer. Because estrogen metabolism may affect breast cancer risk and can be altered by weight and HT, it might play a role in the HT–BMI–breast cancer associations. We undertook a nested case

Variations in sex hormone metabolism gen
✍ Pedram Razavi; Eunjung Lee; Leslie Bernstein; David Van Den Berg; Pamela L. Horn πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 806 KB

## Abstract We investigated whether variants in sex steroid hormone metabolism genes modify the effect of hormone therapy (HT) on endometrial cancer risk in postmenopausal non‐Hispanic white women. A nested case–control study was conducted within the California Teachers Study (CTS). We genotyped ht